Search

everythinglearnresearchcommunity

for

Search:↓

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Skin can produce blood cells, often due to disease, which might lead to new treatments for skin and blood conditions.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

A CCS patient with severe complications was successfully treated using combined therapies.

Tay syndrome is a unique genetic disorder causing skin, hair, and developmental issues.

Zinc levels remained low despite treatment, likely due to absorption issues.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Avacopan may cause unexpected side effects, so early monitoring is important.

TNF-alpha inhibitors can cause various immune-related skin issues.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Most children with skin inflammation taking methotrexate had lab abnormalities, but liver issues often improved without changing the medication dose.

Screening for the NUDT15 gene variant can prevent severe side effects from thiopurine drugs in East-Asian people.

Frequent blood transfusions in beta thalassemia patients can lead to thyroid problems.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

A baby with KID syndrome died from infections and organ failure at 18 months old.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Calprotectin starves Pseudomonas aeruginosa of essential metals, affecting its growth and resistance.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Frequent blood transfusions in beta thalassemia can lead to thyroid problems.

Radiation cystitis patients need better monitoring and early treatment due to higher readmission rates.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.